Trial Profile
Multicentre, Multinational, Double-Blind, Placebo-Controlled, Randomised Phase II Trial of Desmoteplase (INN) in the Indication of Acute Ischaemic Stroke
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Apr 2008
Price :
$35
*
At a glance
- Drugs Desmoteplase (Primary)
- Indications Embolism and thrombosis; Stroke
- Focus Therapeutic Use
- Acronyms DIAS
- Sponsors PAION
- 12 Mar 2008 Added sponsor, from clinicaltrials.gov record.
- 18 Apr 2006 New trial record.